RICCARDO, FLAVIA
 Distribuzione geografica
Continente #
NA - Nord America 546
EU - Europa 270
AS - Asia 148
SA - Sud America 5
AF - Africa 4
Totale 973
Nazione #
US - Stati Uniti d'America 541
IT - Italia 197
SG - Singapore 75
CN - Cina 28
IN - India 22
ID - Indonesia 21
FI - Finlandia 18
BG - Bulgaria 14
SE - Svezia 8
FR - Francia 7
DE - Germania 6
UA - Ucraina 6
BR - Brasile 4
CA - Canada 4
GB - Regno Unito 4
RO - Romania 3
ES - Italia 2
IE - Irlanda 2
MA - Marocco 2
AR - Argentina 1
GH - Ghana 1
IR - Iran 1
KR - Corea 1
MX - Messico 1
NL - Olanda 1
RS - Serbia 1
RU - Federazione Russa 1
TG - Togo 1
Totale 973
Città #
Fairfield 86
Singapore 54
Rome 52
Des Moines 44
Houston 42
Ashburn 40
Woodbridge 40
Seattle 34
Wilmington 33
Chandler 30
Milan 28
Cambridge 27
Jakarta 21
Beijing 17
San Paolo di Civitate 16
Princeton 11
New York 10
Sofia 10
Lawrence 8
Plano 8
Ann Arbor 7
Lappeenranta 7
Boston 6
Marseille 6
Millbury 5
Pescara 5
San Diego 5
Santa Clara 5
Boardman 4
Ottawa 4
Reggio Emilia 4
Andover 3
Bologna 3
Cesena 3
Helsinki 3
Lodi 3
Naples 3
Terni 3
Bari 2
Blumenau 2
Bühl 2
Cagliari 2
Calenzano 2
Campobasso 2
Casablanca 2
Castelvetro Piacentino 2
Colorno 2
Dublin 2
Faridabad 2
Florence 2
Frankfurt am Main 2
Genoa 2
Guangzhou 2
Guaíba 2
Hefei 2
Isorella 2
Nanjing 2
Norwalk 2
Palermo 2
Phoenix 2
Pocasset 2
San Giovanni la Punta 2
Accra 1
Armunia 1
Belgrade 1
Bremen 1
Buenos Aires 1
Chieti 1
City of Westminster 1
Falls Church 1
Hounslow 1
Jacksonville 1
Jinan 1
Kish 1
Leawood 1
Levate 1
Lomé 1
Malo 1
Mexico City 1
Moricone 1
Oxford 1
Pontenure 1
Ravenna 1
Redwood City 1
Rieti 1
Sandston 1
Shenyang 1
St Petersburg 1
Strevi 1
Terracina 1
Turin 1
Urbino 1
Wenzhou 1
Wuhan 1
Yongin-si 1
Totale 771
Nome #
Towards a european framework to monitor infectious diseases among migrant populations: design and applicability 89
Immunization strategies targeting newly arrived migrants in Non-EU countries of the mediterranean basin and black sea 87
Clinical characteristics of hospitalized individuals dying with COVID-19 by Age Group in Italy 79
An early warning system based on syndromic surveillance to detect potential health emergencies among migrants: results of a two-year experience in Italy 76
Screening for infectious diseases among newly arrived migrants in EU/EEA countries--varying practices but consensus on the utility of screening 74
Syndromic surveillance of epidemic-prone diseases in response to an influx of migrants from North Africa to Italy, May to October 2011 68
Meningiti, meningo-encefaliti ed encefaliti da virus Toscana in Italia, 2016-2021. Punta dell’iceberg di una arbovirosi endemica poco conosciuta 62
Key dimensions for the prevention and control of communicable diseases in institutional settings. a scoping review to guide the development of a tool to strengthen preparedness at migrant holding centres in the EU/EEA 62
Monitoraggio sugli operatori sanitari risultati positivi a COVID-19 dall’inizio dell’epidemia fino al 30 aprile 2020: studio retrospettivo in sette regioni italiane 57
Deregulation of microRNAs mediated control of carnitine cycle in prostate cancer: molecular basis and pathophysiological consequences 53
Impact of the 2023/24 autumn-winter COVID-19 seasonal booster campaign in preventing severe COVID-19 cases in Italy (October 2023–March 2024) 49
Factors Influencing the Accuracy of Infectious Disease Reporting in Migrantsa. A Scoping Review 41
Il sistema di sorveglianza basato su eventi in Italia dal 2009 al 2021. Verso una intelligence di sanità pubblica 37
Relative effectiveness of a 2nd booster dose of COVID-19 mRNA vaccine up to four months post administration in individuals aged 80 years or more in Italy. A retrospective matched cohort study 29
Rapid increase in neuroinvasive west Nile virus infections in humans, Italy, July 2022 27
Impatto del COVID-19 dopo l’inizio della vaccinazione in gruppi di popolazione a rischio, tra cui gli immunocompromessi. Italia 2021-2023 22
Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy. A retrospective analysis of January-April, 2022 17
Relative effectiveness of monovalent and bivalent mrna boosters in preventing severe covid-19 due to omicron ba.5 infection up to 4 months post-administration in people aged 60 years or older in Italy. A retrospective matched cohort study 16
Estimated effectiveness of a primary cycle of protein recombinant vaccine nvx-cov2373 against COVID-19 16
Initial impact of SARS-Cov-2 vaccination on healthcare workers in Italy. Update on the 28th of march 2021 14
Lack of evidence of Chikungunya virus infection among blood donors during the Chikungunya outbreak in Lazio Region, Italy, 2017 13
Impatto della vaccinazione e della pregressa diagnosi sul rischio di infezione e di malattia severa associata a SARS-CoV-2. Un’analisi dei casi diagnosticati nel mese di ottobre 2022 12
Relative effectiveness of bivalent Original/Omicron BA.4-5 mRNA vaccine in preventing severe COVID-19 in persons 60 years and above during SARS-CoV-2 Omicron XBB.1.5 and other XBB sublineages circulation, Italy, April to June 2023 11
Effectiveness against severe COVID-19 of a seasonal booster dose of bivalent (original/Omicron BA.4-5) mRNA vaccines in persons aged ≥60 years. Estimates over calendar time and by time since administration during prevalent circulation of different Omicron subvariants, Italy, 2022–2023 11
Socioeconomic inequalities in SARS-CoV-2 infection and COVID-19 health outcomes in urban Italy during the COVID-19 vaccine rollout, January–November 2021 9
Risk of breakthrough infection and hospitalisation after COVID-19 primary vaccination by HIV status in four Italian regions during 2021 8
Intelligent Natural Language Processing for Epidemic Intelligence 6
Increasing situational awareness through nowcasting of the reproduction number 6
Infezione da SARS-CoV-2: minore gravità clinica della variante Omicron rispetto alla variante Delta 6
Valutazione di modelli basati sul Propensity Score per la stima dell’efficacia vaccinale contro forme gravi di COVID-19 in studi di coorte retrospettivi 5
Spatial spread of COVID-19 during the early pandemic phase in Italy 4
Totale 1.066
Categoria #
all - tutte 3.965
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.965


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020178 0 0 0 3 18 19 32 33 28 14 19 12
2020/202160 12 11 2 5 3 1 1 4 10 4 6 1
2021/2022131 0 6 16 4 14 3 1 17 7 7 30 26
2022/2023116 19 30 3 10 14 12 3 10 9 2 2 2
2023/2024264 5 14 11 43 16 34 4 26 11 20 31 49
2024/2025192 25 43 24 100 0 0 0 0 0 0 0 0
Totale 1.066